A valuation gap of nearly 94% separates where NuScale Power (NYSE: SMR) shares currently trade from the $100 fair value assigned by the most widely followed investment thesis on the stock.
That enormous spread has emerged against the backdrop of a bruising 12 months, during which NuScale’s share price shed 85.99% on a one-year total shareholder return basis.
Year-to-date losses alone stand at 63.7%, leaving the stock at a last close of $5.92 and raising the question of whether the selloff has created a genuine entry point or merely reflects deteriorating fundamentals.
The three-year total shareholder return, however, remains in positive territory at 70.11%, a reminder that the company’s longer-arc story has not been entirely erased.
Into this difficult price environment, NuScale signed a manufacturing contract with Doosan Enerbility covering the production of upper reactor pressure vessel and coolant system components, pushing its small modular reactor program closer to commercial reality.
The deal matters structurally because it moves the technology from design certification into physical supply chains, a step that separates speculative nuclear ventures from those with credible paths to deployment.
The bull case, authored by an analyst identified as Delphic, rests on the premise that NuScale’s certified reactor design positions it to supply firm, carbon-free power to the infrastructure segment growing fastest in American energy demand: AI data centers.
Hyperscalers have made binding commitments to carbon-neutral electricity, and as Delphic’s narrative argues, solar and wind cannot deliver the uninterrupted baseload that large-scale computation physically requires.
The $100 fair value figure is derived using a discount rate of 9.69%, a forward price-to-earnings multiple of 34.01, and an assumed profit margin of 8.55%, all of which reflect the long capital commitment cycles typical of infrastructure-scale energy projects.
Wall Street sits considerably more conservative, with a consensus analyst price target of $10.73, representing roughly 44.84% upside from the last close, though even that figure carries little statistical weight given the wide disagreement among forecasters.
The distance between $5.92, $10.73, and $100 encapsulates the fundamental difficulty in pricing NuScale: outcomes hinge almost entirely on whether its reactors transition from licensing milestones into sustained revenue-generating deployment.
Risks to the thesis are concrete, including the possibility that project timelines slip further or that the high upfront capital costs of modular nuclear construction push prospective customers toward less expensive power alternatives.
For investors weighing those risks against the potential reward, the Doosan manufacturing agreement at least provides evidence that the company is advancing through the physical stages of commercialization rather than remaining purely a paper program.
